Qube Research & Technologies Ltd - DIREXION SHS ETF TR ownership

DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 14 filers reported holding DIREXION SHS ETF TR in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of DIREXION SHS ETF TR
ValueSharesWeighting
Q3 2023$6,463
+372.8%
73
-27.0%
0.00%
Q2 2023$1,367
-99.1%
100
-92.2%
0.00%
-100.0%
Q4 2022$147,581
-42.1%
1,286
-57.3%
0.00%
-50.0%
Q3 2022$255,000
+390.4%
3,014
+500.4%
0.00%
Q2 2022$52,000
+642.9%
502
+904.0%
0.00%
Q1 2022$7,000
-96.1%
50
-95.9%
0.00%
-100.0%
Q4 2021$178,000
-44.4%
1,230
-58.7%
0.00%
-75.0%
Q3 2021$320,000
+58.4%
2,977
+54.3%
0.00%
+100.0%
Q2 2021$202,000
+1088.2%
1,929
+864.5%
0.00%
Q1 2021$17,0002000.00%
Other shareholders
DIREXION SHS ETF TR shareholders Q1 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 55,597$2,523,0000.14%
Traynor Capital Management, Inc. 7,481$341,0000.12%
Virtu Financial LLC 49,149$2,230,0000.10%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 2,436$111,0000.08%
Capital Analysts, LLC 6,000$272,0000.03%
Acorn Wealth Advisors, LLC 395$18,0000.02%
BANQUE PICTET & CIE SA 10,120$459,0000.01%
Citadel Advisors 78,471$3,560,0000.00%
WOLVERINE TRADING, LLC 22,300$960,0000.00%
JANE STREET GROUP, LLC 21,346$968,0000.00%
View complete list of DIREXION SHS ETF TR shareholders